Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease

From Owlstone Medical LtdApr 25 2024Reviewed by Lily Ramsey, LLM Owlstone Medical , the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation .

Owlstone, with support from the foundation, is interested in developing new cost-effective detection technologies for volatile organic compounds that could serve as markers of diseases that disproportionately affect the developing world. With the new funding, Owlstone seeks to understand whether this approach is suitable for TB and HIV detection and to explore a path by which breath-based testing could be deployed for rapid screening and earlier diagnosis.

The $1.5 million in grant funding to support the identification of breath biomarkers will be used across two projects:

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Can studying the microbiome help with cancer research?In this article, Owlstone explores the intersection between cancer and microbiome, and how studying microbial species could hold the key to better cancer research.
Source: NewsMedical - 🏆 19. / 71 Read more »

Is inflammation a reliable source of biomarkers for disease?In this article, Owlstone discusses inflammation’s relevance to disease diagnosis and whether it can be considered a biomarker.
Source: NewsMedical - 🏆 19. / 71 Read more »